M0678
Middlebrook OADC Growth Supplement
Enrichment supplement recommended for isolation and cultivation of Mycobacteria, suitable for microbiology
Synonym(s):
Middlebrook Oleic Albumin Dextrose Catalase Growth Supplement, Oleic Albumin Dextrose Catalase
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.85
UNSPSC Code:
41171614
Quality Level
sterility
sterile (Filtered and Aseptic Handled)
form
liquid
shelf life
limited shelf life, expiry date on the label
packaging
vial of 50 mL
application(s)
clinical testing
environmental
food and beverages
life science and biopharma
veterinary, microbiology
storage temp.
2-8°C
suitability
mycobacteria
General description
Middlebrook OADC Growth Supplement is used with the Middlebrook Agar, that allows the isolation and cultivation of a wide variety of Mycobacteria. Middlebrook OADC Growth Supplement contains oleic acid, bovine albumin, sodium chloride, dextrose, and catalase. Oleic acid and other long chain fatty acids are essential for the metabolism of Mycobacteria. Some free fatty acids are toxic to Mycobacteria, but albumin binds to those fatty acids and prevents toxic action on Mycobacteria. Dextrose is the fermentable carbohydrate and an energy source whereas catalase destroys toxic peroxides that may be present in the medium.
Application
Middlebrook OADC growth supplement has been used as a supplement in 7H9 liquid medium to culture mycobacteria from clinical samples, environmental, food and beverages.
Other Notes
Ingredients: (per vial)
Bovine Albumin Fraction V 2.50 g
Dextrose 1.00 g
Catalase 0.002 g
Oleic acid 0.025 g
Sodium chloride 0.425 g
Distilled water 50 mL
Bovine Albumin Fraction V 2.50 g
Dextrose 1.00 g
Catalase 0.002 g
Oleic acid 0.025 g
Sodium chloride 0.425 g
Distilled water 50 mL
Storage Class
12 - Non Combustible Liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves
Regulatory Information
低风险生物材料
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
Soto JA, et al.
Frontiers in immunology, 9 (2018)
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
Soto JA, et al.
Frontiers in Immunology, 9 (2018)
Detecting phenotypically resistant Mycobacterium tuberculosis using wavelength modulated Raman spectroscopy
Antibiotic resistance protocols, 41-50 (2018)